Tandem Diabetes Care [TNDM] vs Enovis [ENOV] Detailed Stock Comparison

Tandem Diabetes Care

NASDAQ

Enovis

NYSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Tandem Diabetes Care wins in 9 metrics, Enovis wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric	Tandem Diabetes Care	Enovis	Better
P/E Ratio (TTM)	-7.27	-2.04	Tandem Diabetes Care
Price-to-Book Ratio	5.52	0.66	Enovis
Debt-to-Equity Ratio	340.56	56.75	Enovis
PEG Ratio	-0.11	-0.02	Tandem Diabetes Care
EV/EBITDA	-11.52	8.58	Tandem Diabetes Care
Profit Margin (TTM)	-20.51%	-37.80%	Tandem Diabetes Care
Operating Margin (TTM)	-13.24%	2.41%	Enovis
EBITDA Margin (TTM)	N/A	2.41%	N/A
Return on Equity	-111.92%	-28.25%	Enovis
Return on Assets (TTM)	-6.41%	0.89%	Enovis
Free Cash Flow (TTM)	$4.99M	$-67.21M	Tandem Diabetes Care
1-Year Return	-75.22%	-35.91%	Enovis
Price-to-Sales Ratio (TTM)	0.73	0.77	Tandem Diabetes Care
Enterprise Value	$874.38M	$3.11B	Enovis
EV/Revenue Ratio	0.87	1.42	Tandem Diabetes Care
Gross Profit Margin (TTM)	52.29%	59.29%	Enovis
Revenue per Share (TTM)	$15	$39	Enovis
Earnings per Share (Diluted)	$-3.08	$-14.95	Tandem Diabetes Care
Beta (Stock Volatility)	1.47	1.81	Tandem Diabetes Care

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Tandem Diabetes Care vs Enovis Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Tandem Diabetes Care	7.92%	3.66%	-24.47%	-48.96%	-64.35%	-69.17%
Enovis	6.58%	2.36%	12.17%	-8.81%	-30.93%	-33.41%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Tandem Diabetes Care	-75.22%	-76.33%	-90.22%	-90.56%	-94.94%	-94.94%
Enovis	-35.91%	-43.59%	-48.99%	-55.93%	31.34%	-16.38%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Tandem Diabetes Care (TNDM): View Full Stock Overview

Enovis (ENOV): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Tandem Diabetes Care vs Enovis

Metric	TNDM	ENOV
Market Information
Market Cap i	$735.83M	$1.69B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	3,752,020	1,248,445
90 Day Avg. Volume i	2,384,093	1,487,105
Last Close	$11.93	$31.44
52 Week Range	$9.98 - $47.60	$25.47 - $49.83
% from 52W High	-74.95%	-36.91%
All-Time High	$302.50 (Jan 13, 2014)	$129.72 (Jun 09, 2014)
% from All-Time High	-96.06%	-75.76%
Growth Metrics
Quarterly Revenue Growth	0.09%	0.08%
Quarterly Earnings Growth	N/A	0.08%
Financial Health
Profit Margin (TTM) i	-0.21%	-0.38%
Operating Margin (TTM) i	-0.13%	0.02%
Return on Equity (TTM) i	-1.12%	-0.28%
Debt to Equity (MRQ) i	340.56	56.75
Cash & Liquidity
Book Value per Share (MRQ)	$1.97	$45.11
Cash per Share (MRQ)	$4.67	$0.77
Operating Cash Flow (TTM) i	$9.72M	$188.06M
Levered Free Cash Flow (TTM) i	$31.96M	$65.68M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	$0.00

Valuation & Enterprise Metrics Analysis: Tandem Diabetes Care vs Enovis

Metric	TNDM	ENOV
Price Ratios
P/E Ratio (TTM) i	-7.27	-2.04
Forward P/E i	-9.00	9.35
PEG Ratio i	-0.11	-0.02
Price to Sales (TTM) i	0.73	0.77
Price to Book (MRQ) i	5.52	0.66
Market Capitalization
Market Capitalization i	$735.83M	$1.69B
Enterprise Value i	$874.38M	$3.11B
Enterprise Value Metrics
Enterprise to Revenue i	0.87	1.42
Enterprise to EBITDA i	-11.52	8.58
Risk & Other Metrics
Beta i	1.47	1.81
Book Value per Share (MRQ) i	$1.97	$45.11

Financial Statements Comparison: Tandem Diabetes Care vs Enovis

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	TNDM	ENOV
Revenue/Sales i	$234.42M	$558.83M
Cost of Goods Sold i	$116.02M	$226.61M
Gross Profit i	$118.41M	$332.23M
Research & Development i	$125.43M	$28.53M
Operating Income (EBIT) i	$-120.88M	$-42.91M
EBITDA i	$-116.42M	$27.14M
Pre-Tax Income i	$-122.09M	$-57.35M
Income Tax i	$8.47M	$-1.77M
Net Income (Profit) i	$-130.56M	$-55.71M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	TNDM	ENOV
Cash & Equivalents i	$53.57M	$38.46M
Total Current Assets i	$663.44M	$1.22B
Total Current Liabilities i	$288.18M	$477.42M
Long-Term Debt i	$431.75M	$1.42B
Total Shareholders Equity i	$155.29M	$2.62B
Retained Earnings i	$-1.18B	$-338.99M
Property, Plant & Equipment i	$79.22M	$492.24M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	TNDM	ENOV
Operating Cash Flow i	$-6.71M	$-1.07M
Capital Expenditures i	$-6.21M	$-43.26M
Free Cash Flow i	$-15.70M	$-44.86M
Debt Repayment i	$-40.76M	$-15.44M
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	TNDM	ENOV
Shares Short i	8.75M	6.88M
Short Ratio i	4.75	4.60
Short % of Float i	0.18%	0.18%
Average Daily Volume (10 Day) i	3,752,020	1,248,445
Average Daily Volume (90 Day) i	2,384,093	1,487,105
Shares Outstanding i	66.26M	55.88M
Float Shares i	61.84M	56.45M
% Held by Insiders i	0.01%	0.02%
% Held by Institutions i	1.21%	1.21%

Dividend Analysis & Yield Comparison: Tandem Diabetes Care vs Enovis

Metric	TNDM	ENOV
Last 12-Month Dividend i	N/A	$0.00
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	$0.00
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	$0.00
Ex-Dividend Date	N/A	N/A

Tandem Diabetes Care [TNDM] vs Enovis [ENOV] Detailed Stock Comparison